Impact of SARS-CoV-2 Vaccination on Disease Activity and Severity of COVID-19 Infection in Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study.
Sartori NS, Machado KLLL, Miyamoto ST, Pretti FZ, Gouveia MDPG, Oliveira YGP, da Silva VG, Faé F, Burian APN, Tapia KRL, Moulin ACS, Grillo LL, Athayde PDS, Corona HDS, Ramos SS, Peixoto FMMMC, Ribeiro PDC, Magalhães VO, de Aguiar MF, Biegelmeyer E, Kayser C, De Souza AWS, Castro CHM, Bühring J, Ribeiro SLE, Oliveira Dos Santos SH, Martins CP, da Silva Rodrigues JW, Sousa Dias MM, Dutra BG, Telles CMPF, Basualto Dias SE, de Rezende RPV, Baptista KL, Gaudio RC, de Melo AKG, da Silva VB, Cruz VA, Rêgo J, Vieira RMRA, Vieira ASR, Kakehasi AM, Tavares ACFMG, Pereira AJA, da Costa PVT, Azevedo VF, Pamplona Bueno de Andrade N, Tres GL, Assis Martins-Filho O, Peruhype-Magalhães V, Valim V, Ferreira GA, Teixeira-Carvalho A, Dos Reis-Neto ET, Sato EI, Pinheiro MM, de Souza VA, Xavier RM, Pileggi GS, Monticielo OA; SAFER-Study Group Task Force.
Sartori NS, et al.
Vaccines (Basel). 2025 Oct 21;13(10):1074. doi: 10.3390/vaccines13101074.
Vaccines (Basel). 2025.
PMID: 41150460
Free PMC article.